Dianhong Zhang

612 total citations
17 papers, 371 citations indexed

About

Dianhong Zhang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Dianhong Zhang has authored 17 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Cell Biology. Recurrent topics in Dianhong Zhang's work include Ubiquitin and proteasome pathways (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Signaling Pathways in Disease (3 papers). Dianhong Zhang is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Signaling Pathways in Disease (3 papers). Dianhong Zhang collaborates with scholars based in China and Indonesia. Dianhong Zhang's co-authors include Leiming Wu, Binbin Du, Yanzhou Zhang, Rui Yao, Cui Liang, Lu Gao, Zhen Huang, Lingyao Kong, Zheng Wang and Lili Xiao and has published in prestigious journals such as Hepatology, Free Radical Biology and Medicine and Experimental Cell Research.

In The Last Decade

Dianhong Zhang

17 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dianhong Zhang China 12 224 97 60 60 44 17 371
Shunlin Qu China 14 293 1.3× 123 1.3× 59 1.0× 53 0.9× 47 1.1× 21 470
Xing Chang China 10 254 1.1× 45 0.5× 55 0.9× 73 1.2× 37 0.8× 20 412
Jiayu Jin China 8 321 1.4× 71 0.7× 52 0.9× 72 1.2× 37 0.8× 12 463
Zhulan Cai China 12 251 1.1× 63 0.6× 127 2.1× 53 0.9× 62 1.4× 16 425
Qingwen Xie China 11 205 0.9× 49 0.5× 93 1.6× 64 1.1× 46 1.0× 19 382
Haixu Song China 11 238 1.1× 66 0.7× 86 1.4× 122 2.0× 36 0.8× 29 450
Sujie Jia China 14 200 0.9× 83 0.9× 28 0.5× 35 0.6× 78 1.8× 26 413
Songping Yu China 12 182 0.8× 65 0.7× 27 0.5× 57 0.9× 28 0.6× 25 398
Xuanke Guan China 8 255 1.1× 39 0.4× 75 1.3× 83 1.4× 31 0.7× 16 413
Wanwen Cheng China 8 193 0.9× 58 0.6× 120 2.0× 42 0.7× 56 1.3× 11 361

Countries citing papers authored by Dianhong Zhang

Since Specialization
Citations

This map shows the geographic impact of Dianhong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianhong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianhong Zhang more than expected).

Fields of papers citing papers by Dianhong Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianhong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianhong Zhang. The network helps show where Dianhong Zhang may publish in the future.

Co-authorship network of co-authors of Dianhong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Dianhong Zhang. A scholar is included among the top collaborators of Dianhong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianhong Zhang. Dianhong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Du, Binbin, Jielei Zhang, Lingyao Kong, et al.. (2023). Ovarian Tumor Domain‐Containing 7B Attenuates Pathological Cardiac Hypertrophy by Inhibiting Ubiquitination and Degradation of Krüppel‐Like Factor 4. Journal of the American Heart Association. 12(24). e029745–e029745. 1 indexed citations
2.
Li, Huan, Qin Yang, Zhen Huang, et al.. (2022). Dual-specificity phosphatase 12 attenuates oxidative stress injury and apoptosis in diabetic cardiomyopathy via the ASK1-JNK/p38 signaling pathway. Free Radical Biology and Medicine. 192. 13–24. 14 indexed citations
3.
Kong, Lingyao, Cui Liang, Pengcheng Li, et al.. (2022). Myotubularin‐Related Protein14 Prevents Neointima Formation and Vascular Smooth Muscle Cell Proliferation by Inhibiting Polo‐Like Kinase1. Journal of the American Heart Association. 11(21). e026174–e026174. 2 indexed citations
4.
Yang, Lulu, Huan Li, Dianhong Zhang, et al.. (2022). E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING. Cell Death and Disease. 13(10). 889–889. 18 indexed citations
5.
Zhang, Jielei, Binbin Du, Dianhong Zhang, et al.. (2021). OTUB1 alleviates NASH through inhibition of the TRAF6‐ASK1 signaling pathways. Hepatology. 75(5). 1218–1234. 26 indexed citations
6.
Zhang, Dianhong, Cui Liang, Pengcheng Li, et al.. (2021). Runt‐related transcription factor 1 (Runx1) aggravates pathological cardiac hypertrophy by promoting p53 expression. Journal of Cellular and Molecular Medicine. 25(16). 7867–7877. 12 indexed citations
7.
Du, Binbin, Fang Wang, Leiming Wu, et al.. (2020). Cause-specific mortality after diagnosis of thyroid cancer: a large population-based study. Endocrine. 72(1). 179–189. 21 indexed citations
8.
Huang, Zhen, Leiming Wu, Dianhong Zhang, et al.. (2020). Hsa_circ_0029589 knockdown inhibits the proliferation, migration and invasion of vascular smooth muscle cells via regulating miR-214-3p and STIM1. Life Sciences. 259. 118251–118251. 28 indexed citations
9.
Zhang, Jielei, Dianhong Zhang, Yapeng Li, et al.. (2020). Myotubularin-related protein 14 suppresses cardiac hypertrophy by inhibiting Akt. Cell Death and Disease. 11(2). 140–140. 11 indexed citations
10.
Zhang, Dianhong, Jielei Zhang, Zhen Huang, et al.. (2020). Deubiquitinase Ubiquitin‐Specific Protease 10 Deficiency Regulates Sirt6 signaling and Exacerbates Cardiac Hypertrophy. Journal of the American Heart Association. 9(22). e017751–e017751. 28 indexed citations
11.
Teng, Qiaoqiao, Shufeng Ma, Jiang Liu, et al.. (2020). Removal of wastewater phenolic compounds with triethylenetetramine functionalized polystyrene resin. Water Science & Technology. 82(3). 440–453. 1 indexed citations
12.
Gao, Lu, Dianhong Zhang, Xinyu Tian, et al.. (2019). MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2. International Journal of Biological Sciences. 15(12). 2615–2626. 66 indexed citations
13.
Zhang, Dianhong, et al.. (2019). Research on Humanistic Technology of Urban Design of Historical Blocks in Harbin. 1 indexed citations
15.
Li, Yapeng, Dianhong Zhang, Lingyao Kong, et al.. (2018). Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling. Experimental Cell Research. 370(1). 78–86. 19 indexed citations
16.
Wu, Leiming, Lu Gao, Dianhong Zhang, et al.. (2018). C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway. Free Radical Biology and Medicine. 121. 215–230. 37 indexed citations
17.
Gao, Lu, Rui Yao, Yuzhou Liu, et al.. (2017). Isorhamnetin protects against cardiac hypertrophy through blocking PI3K–AKT pathway. Molecular and Cellular Biochemistry. 429(1-2). 167–177. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026